Cargando…
Treatment of rituximab in patients with idiopathic membranous nephropathy: a case series and literature review
BACKGROUND/AIMS: Membranous nephropathy (MN) is a major cause of nephrotic syndrome in adults. This study aimed to evaluate the effect of rituximab (RTX) in patients with idiopathic MN (iMN) who have a high risk of progression. METHODS: We retrospectively analyzed data of 13 patients with iMN, who r...
Autores principales: | Jeon, Soo-Jee, Kim, Ji-Hye, Noh, Hee-Won, Lee, Ga-Young, Lim, Jeong-Hoon, Jung, Hee-Yeon, Cho, Jang-Hee, Choi, Ji-Young, Kim, Chan-Duck, Kim, Yong-Lim, Park, Sun-Hee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Association of Internal Medicine
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271724/ https://www.ncbi.nlm.nih.gov/pubmed/35421909 http://dx.doi.org/10.3904/kjim.2021.155 |
Ejemplares similares
-
Idiopathic membranous nephropathy in older patients: Clinical features and outcomes
por: Choi, Ji-Young, et al.
Publicado: (2020) -
Higher Serum Total Cholesterol to High-Density Lipoprotein Cholesterol Ratio Is Associated with Increased Mortality among Incident Peritoneal Dialysis Patients
por: Noh, Hee-Won, et al.
Publicado: (2021) -
Two cases of idiopathic membranous nephropathy treated with rituximab
por: Young Yoon, Jae, et al.
Publicado: (2013) -
Anti-phospholipase A2 receptor antibody as a prognostic marker in patients with primary membranous nephropathy
por: Song, Eun Joo, et al.
Publicado: (2018) -
Impact of gene polymorphisms of interleukin-18, transforming growth factor-β, and vascular endothelial growth factor on development of IgA nephropathy and thin glomerular basement membrane disease
por: Jung, Hee-Yeon, et al.
Publicado: (2012)